NCT00073723View on ClinicalTrials.gov

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

January 31, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

ABI-007

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY

NCT00073723 - Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter